Neuronet publishes series of project introduction videos during Brain Awareness Week
The Neuronet programme launched a series of short introduction videos of the various Innovative Medicines
MOPEAD
Tackling the under-detection and late diagnosis of Alzheimer’s disease
For care planning and support, under-detection and late diagnosis of Alzheimer’s disease (AD) is a
Neuronet launches its social media campaign “Programme impact analysis – where we are and where we need to go”
The Neuronet project is setting up an efficient platform to boost collaboration across research projects
Neuronet Working Groups emphasise the importance of effective collaboration to overcome obstacles linked to patient privacy and data sharing
As a coordination and support action, Neuronet has been designed to enhance the impact and
Communication representatives of neurodegeneration research projects exchange on best practices
On 7 May, representatives of 12 Innovative Medicines Initiative neurodegeneration research projects met virtually to
Neuronet convenes 6th meeting of its Scientific Coordination Board
On 22 March, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened
Spotlight on early-career researchers: a Neuronet interview with Lena Sannemann
Photo credit: Michael Wodak / MedizinFotoKöln In this Neuronet interview, we talk to Lena Sannemann
Research Programme on Neurodegeneration Featured at Alzheimer Europe Conference
In 2019, the Neuronet Sessions introduced the projects of the Innovative Medicines Initiative (IMI) neurodegeneration
EFPIA publishes a guest blog on IMI impact: collaboration is key to dementia challenge
On November 3rd, the European Federation of Pharmaceutical Industries and Associations (EFPIA) published a blog
Showcasing IMI projects: Neuronet at #30AEC
Neuronet has been designed to boost synergy and collaboration across the projects of the Innovative